The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...
President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.
Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, ...
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
The U.S. Centers for Medicare & Medicaid Services, or CMS, said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated under the Inflation ...
The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...
The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.
Health programs were among the subjects of a flurry of executive orders signed by President Donald Trump soon after his inauguration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback